Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp. NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc. (OTC PINK:EBYH) Strainsforpains, Inc. has entered into a strategic partnership with GenBio to license potentially new...

Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- -- (E-Buy Homes, Inc. DBA/Strainsforpains, Inc.) (OTC Markets: EBYH) Strainsforpains, Inc. is pleased to announce the successful acquisition of a...

Strainsforpains Inc. Announces Corporate Update NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- (Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains is pleased to announce that it has increased the capacity of its Pennsylvania facility to...

Strainsforpains, Inc. secures its largest orders to date from NYC establishments NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc. Announces Corporate Update (Strainsforpains, Inc.) (OTC Markets: EBYH). Strainsforpains, Inc. is pleased to announce it has...

Strainsforpains, Inc. Provides Corporate Update New York, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Strainsforpains, Inc. (OTC Pink:EBYH) is pleased to announce a shareholder update.  As our focus since 2016 has been cannabis...